All In Biotech

Drug Trial Radar · NCT06524830

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 142 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

142

Actual

Start

Dec 30, 2024

Primary completion

Jul 30, 2026

Study completion Oct 16, 2026

Sponsor

Lead sponsor
atai Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jul 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmucosal buccal film (VLS-01-BU) in patients with treatment resistant Major Depressive disorder (TRD) and will characterize the onset and durability of antidepressant effects of VLS-01-BU versus placebo.

Conditions

  • Treatment Resistant Depression

Interventions

  • VLS-01-203 BUDrug

    VLS-01 buccal transmucosal administration

  • VLS-01-BU PlaceboDrug

    Placebo buccal transmucosal administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) total scoreTime frame: Baseline to Day 29

Locations

48 sites in 4 countries. Site status is shown where the registry gives one.

  • Noble Clinical Research

    Tucson, Arizona

  • Pillar Clinical Research, LLC

    Little Rock, Arkansas

  • Preferred Research Partners, Inc.

    Little Rock, Arkansas

  • Woodland Research Northwest

    Rogers, Arkansas

  • CenExel

    Garden Grove, California

  • Behavioral Research Specialists, LLC

    Glendale, California

  • Kadima Neuropsychiatry Institute

    La Jolla, California

  • Collaborative Neuroscience Research, LLC

    Los Alamitos, California

  • TRIP Clinical at Psychedelic Science Institute

    Santa Monica, California

  • Mountain View Clinical Research Inc.

    Denver, Colorado

  • CenExel

    Hollywood, Florida

  • Bioresearch Partner

    Miami, Florida

  • University of South Florida, Psychiatry and Behavioral Neurosciences

    Tampa, Florida

  • CenExcel

    Decatur, Georgia

  • CenExel

    Savannah, Georgia

  • Pillar Clinical Research LLC

    Chicago, Illinois

  • Sheppard Pratt

    Baltimore, Maryland

  • Sunstone Medical, PC

    Rockville, Maryland

  • Elixia MA

    Springfield, Massachusetts

  • Adams Clinical

    Watertown, Massachusetts

  • Institute for Integrative Therapies

    Eden Prairie, Minnesota

  • Midwest Research Group

    Saint Charles, Missouri

  • Clinilabs, LLC

    Eatontown, New Jersey

  • Bio Behavioral Health

    Toms River, New Jersey

  • The Medical Research Network, LLC

    New York, New York

  • The Ohio State University

    Columbus, Ohio

  • Neuro Behavioral Clinical Research, Inc.

    North Canton, Ohio

  • Scranton Medical Institute, LLC

    Moosic, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Biobehavioral Research of Austin

    Austin, Texas

  • InSite Clinical Research

    DeSoto, Texas

  • Aim Trials, LLC

    Plano, Texas

  • Cedar Clinical Research Inc

    Draper, Utah

  • Seattle Neuropsychiatric Treatment Center

    Bellevue, Washington

  • Sydney Local Health District (SLHD) Mental Health

    Camperdown, New South Wales, Australia

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • NeuroCentrix

    Carlton, Victoria, Australia

  • The University of Melbourne

    Carlton, Victoria, Australia

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia

  • Paratus Clinical Research Melbourne

    Northcote, Victoria, Australia

Showing 40 of 48 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.